Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors

Volume: 125, Issue: 7, Pages: 544 - 551
Published: Apr 3, 2017
Abstract
BACKGROUND Pancreatic neuroendocrine tumors (PanNETs) frequently use the alternative lengthening of telomeres (ALT) pathway for telomere maintenance. ALT is strongly correlated with α thalassemia‐mental retardation, X linked (ATRX), and death domain‐associated protein 6 (DAXX) alterations and a poor prognosis in patients with primary PanNET. Because fine‐needle aspiration (FNA) is a noninvasive way to sample tumors, the authors evaluated whether...
Paper Details
Title
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
Published Date
Apr 3, 2017
Volume
125
Issue
7
Pages
544 - 551
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.